tiprankstipranks
Abbott Laboratories (MX:ABT)
:ABT
Mexico Market

Abbott Laboratories (ABT) Ratios

0 Followers

Abbott Laboratories Ratios

MX:ABT's free cash flow for Q2 2026 was $0.58. For the 2026 fiscal year, MX:ABT's free cash flow was decreased by $ and operating cash flow was $0.14. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
1.38 1.58 1.67 1.64 1.63
Quick Ratio
0.97 1.18 1.23 1.16 1.23
Cash Ratio
0.29 0.52 0.54 0.50 0.64
Solvency Ratio
0.13 0.27 0.50 0.26 0.27
Operating Cash Flow Ratio
0.56 0.58 0.60 0.52 0.62
Short-Term Operating Cash Flow Coverage
3.30 2.89 4.88 5.48 3.86
Net Current Asset Value
$ -32.94B$ -7.95B$ -9.86B$ -11.72B$ -12.31B
Leverage Ratios
Debt-to-Assets Ratio
0.30 0.17 0.19 0.22 0.24
Debt-to-Equity Ratio
0.64 0.29 0.32 0.41 0.49
Debt-to-Capital Ratio
0.39 0.22 0.24 0.29 0.33
Long-Term Debt-to-Capital Ratio
0.37 0.17 0.21 0.26 0.28
Financial Leverage Ratio
2.14 1.66 1.71 1.90 2.03
Debt Service Coverage Ratio
2.16 2.63 7.31 4.78 3.76
Interest Coverage Ratio
12.45 23.60 11.32 9.22 26.55
Debt to Market Cap
0.17 0.06 0.07 0.08 0.09
Interest Debt Per Share
19.07 8.82 9.17 9.56 10.42
Net Debt to EBITDA
2.77 0.57 0.71 0.85 0.68
Profitability Margins
Gross Profit Margin
56.80%55.51%50.83%49.96%51.14%
EBIT Margin
17.17%19.87%18.15%18.35%19.75%
EBITDA Margin
21.34%26.06%25.83%26.44%27.23%
Operating Profit Margin
17.03%18.16%16.27%16.04%19.16%
Pretax Profit Margin
16.12%19.10%16.72%16.61%19.03%
Net Profit Margin
11.65%14.72%31.95%14.27%15.88%
Continuous Operations Profit Margin
11.65%14.72%31.95%14.27%15.88%
Net Income Per EBT
72.23%77.06%191.10%85.88%83.47%
EBT Per EBIT
94.69%105.19%102.75%103.56%99.33%
Return on Assets (ROA)
4.97%7.52%16.46%7.82%9.31%
Return on Equity (ROE)
10.52%12.51%28.12%14.83%18.90%
Return on Capital Employed (ROCE)
8.68%11.46%10.15%10.84%14.19%
Return on Invested Capital (ROIC)
6.07%8.43%9.89%9.10%11.36%
Return on Tangible Assets
9.56%11.42%25.94%14.05%16.83%
Earnings Yield
2.87%2.98%6.84%3.00%3.60%
Efficiency Ratios
Receivables Turnover
5.42 5.59 6.06 6.11 7.02
Payables Turnover
4.20 4.65 4.92 4.67 4.63
Inventory Turnover
2.75 3.04 3.33 3.06 3.46
Fixed Asset Turnover
3.64 3.43 3.58 3.56 4.25
Asset Turnover
0.43 0.51 0.52 0.55 0.59
Working Capital Turnover Ratio
6.73 4.67 4.58 4.32 4.18
Cash Conversion Cycle
113.10 106.89 95.63 101.11 78.79
Days of Sales Outstanding
67.37 65.29 60.25 59.74 51.99
Days of Inventory Outstanding
132.68 120.08 109.62 119.47 105.63
Days of Payables Outstanding
86.96 78.47 74.24 78.10 78.84
Operating Cycle
200.06 185.37 169.87 179.22 157.62
Cash Flow Ratios
Operating Cash Flow Per Share
5.68 5.48 4.94 4.19 5.47
Free Cash Flow Per Share
5.00 4.23 3.67 2.92 4.45
CapEx Per Share
0.68 1.24 1.27 1.27 1.01
Free Cash Flow to Operating Cash Flow
0.88 0.77 0.74 0.70 0.81
Dividend Paid and CapEx Coverage Ratio
1.82 1.52 1.42 1.26 1.88
Capital Expenditure Coverage Ratio
8.36 4.41 3.88 3.30 5.39
Operating Cash Flow Coverage Ratio
0.30 0.63 0.56 0.46 0.53
Operating Cash Flow to Sales Ratio
0.21 0.22 0.20 0.18 0.22
Free Cash Flow Yield
4.65%3.38%3.24%2.65%4.05%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
34.83 33.50 14.75 33.35 27.76
Price-to-Sales (P/S) Ratio
4.02 4.94 4.67 4.76 4.41
Price-to-Book (P/B) Ratio
3.69 4.20 4.11 4.94 5.25
Price-to-Free Cash Flow (P/FCF) Ratio
21.49 29.60 30.84 37.73 24.66
Price-to-Operating Cash Flow Ratio
19.06 22.88 22.89 26.29 20.09
Price-to-Earnings Growth (PEG) Ratio
-0.57 -0.65 0.11 -2.05 -36.74
Price-to-Fair Value
3.69 4.20 4.11 4.94 5.25
Enterprise Value Multiple
21.62 19.51 18.79 18.84 16.87
Enterprise Value
214.94B 225.43B 203.53B 199.85B 200.53B
EV to EBITDA
21.62 19.51 18.79 18.84 16.87
EV to Sales
4.61 5.09 4.85 4.98 4.59
EV to Free Cash Flow
24.65 30.48 32.05 39.50 25.70
EV to Operating Cash Flow
21.70 23.57 23.78 27.52 20.93
Tangible Book Value Per Share
-0.40 13.29 10.48 3.65 2.08
Shareholders’ Equity Per Share
29.32 29.84 27.52 22.26 20.93
Tax and Other Ratios
Effective Tax Rate
0.28 0.23 -0.91 0.14 0.17
Revenue Per Share
26.73 25.37 24.22 23.13 24.90
Net Income Per Share
3.11 3.73 7.74 3.30 3.95
Tax Burden
0.72 0.77 1.91 0.86 0.83
Interest Burden
0.94 0.96 0.92 0.91 0.96
Research & Development to Revenue
0.07 0.07 0.07 0.07 0.07
SG&A to Revenue
0.29 0.28 0.28 0.00 0.00
Stock-Based Compensation to Revenue
0.02 0.01 0.02 0.02 0.02
Income Quality
1.83 1.47 0.64 1.27 1.38
Currency in USD